Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • Munjal-Burmans bat for...

    Munjal-Burmans bat for level playing field in Fortis bidding

    Written by Ruby Khatun Khatun Published On 2018-05-01T10:00:46+05:30  |  Updated On 1 May 2018 10:00 AM IST
    Munjal-Burmans bat for level playing field in Fortis bidding

    New Delhi: Hero Enterprise and Burman Family Office said that equal opportunity should be provided to all the parties involved in the bidding of Fortis Healthcare.


    "We have just heard about the announcement made by Fortis and are a bit surprised as we had assumed that the final bids were submitted and the process now was only to review and choose the best offer," Sunil Kant Munjal said on the behalf of himself, Mohit Burman and Anand Burman in a statement.



    The entity strongly believes that there should be an equal opportunity given to all bidders without any unfair advantage to any one party, it added.


    Fortis Healthcare yesterday said its board will meet on May 10 to take a decision on the binding bids for the company as recommended by the expert advisory committee (EAC).

    The committee will evaluate all binding bids received by the company from any party except Manipal and TPG consortium till 12 noon on May 1.


    "In line with the obligations towards Manipal and TPG consortium, Manipal and TPG consortium will have the ability to provide a revised financial proposal till 12 noon on May 06, 2018 in relation to all binding bids received by the company anytime till 12 noon on May 1, 2018," Fortis Healthcare had earlier said in a regulatory filing.


    The filing had further said: "In light of the above, EAC constituted by the Board of the company will evaluate all binding bids received from any party till 12 noon on May 01, 2018 and the revised binding financial proposals from the Manipal and TPG Consortium received till 12 noon on May 6, 2018."


    Munjal-Burmans said they still welcome the move by the Fortis and hoped that the FHL board will repose their confidence in their bid.


    "Our offer is already the best one and in the larger interest of Fortis Healthcare, and all those connected with the company's ecosystem- its shareholders, patients, their attendants, doctors, the community and public at large, beside lenders, suppliers, medical and non-medical staff," Munjal said.


    The entity is keen to invest directly in the company and believe this is the best way to create value for all stakeholders, he added.


    FHL has already received binding offers from four entities - KKR-backed Radiant Life Care, Malaysian major IHH Healthcare, Manipal/TPG consortium and Munjal and Burman family offices.

    Anand BurmanBinding bidsBurman Family OfficeBurmansEACexpert advisory committeeFortis HealthcareHero EnterpriseIHH HealthcareManipalMohit BurmanMunjalRadiant Life CareSunil Kant MunjalTPG
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok